Bob Nelsen

Re­silience has caught the eye of the Cana­di­an gov­ern­ment, which will in­vest $163M to boost mR­NA pro­duc­tion

Bob Nelsen’s Re­silience, with a mis­sion no less am­bi­tious than rewrit­ing the rules of drug man­u­fac­tur­ing, has raced off to a quick lead with just …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.